The insider selling is routine in size and timing relative to the post-earnings window. No bearish signal here. Monitor for any open-market sales by CEO Birgit Girshick or CFO Michael Knell in the coming weeks, which would be a more significant signal. The bullish earnings catalyst remains the dominant narrative.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 14 $280.05entry
- T+1 · 3mo ago +2.35%α +2.83% · $286.64
- T+5 · 3mo ago +5.41%α +6.77% · $295.19
- T+20 · 2mo ago −2.48%α −0.49% · $273.11
- T+60 · 8d ago +26.17%α +29.22% · $353.34
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider selling at Charles River Laboratories (CRL) totaling $10.21M occurred within 9 days of the Q2 2026 earnings beat. The selling is concentrated among a director (Foster, $7.9M), a CEVP (Parisotto, $1.04M), and an EVP (Creamer, $1.08M), all of which are open-market sales. While the earnings report was bullish (beat on EPS, raised guidance), the insider sales are likely liquidity-driven, as they coincide with option exercises and vesting, and the total value represents only 0.075% of the $13.6B market cap, falling below the 0.1% materiality threshold. The cluster is not a bearish signal given the small proportional size and the context of post-earnings window openings, but it warrants monitoring for any follow-on sales by the CEO or CFO.
Key Financial Metrics
Key Facts
- Insider cluster of 4 executives sold $10.21M in open-market sales over a 7-day window.
- Director James C. Foster accounted for $7.9M (77%) of the total selling.
- Total sales represent only 0.075% of CRL's $13.6B market cap, below the 0.1% materiality threshold.
- Sales occurred 9 days after a bullish Q2 earnings report (EPS beat by 10.6%, raised guidance).
- Multiple sales coincide with option exercises (non-cash events), suggesting liquidity/vesting-driven selling.
Financial Impact
Insider selling of $10.21M, representing 0.075% of market cap
Risk Factors
- Insider selling could accelerate if the stock continues to rally post-earnings.
- The cluster includes a director selling a large absolute amount ($7.9M), which could be misinterpreted by the market.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CRL-1786691116080 |
Track record
17 reports on CRL
3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +44.25% at T+60 after the Aug 5, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $333.18 Now $335.52 +0.70% settles Dec 15
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $345.80 Now $335.52 −2.97% settles Dec 9
- Nov 9, 20267d ago 8-K Neutral 5/10 Entry $353.34 Now $335.52 −5.04% settles Dec 8
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $313.02 Now $335.52 +7.19% settles Dec 4
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $326.29 Now $335.52 +2.83% settles Dec 3
- Oct 26, 202621d ago Insider Cluster Neutral 2/10 Entry $358.84 Now $335.52 −6.50% settles Nov 24
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $345.37 Now $335.52 −2.85% settles Nov 20
- Oct 21, 202626d ago Institutional Cluster Bullish 4/10 Entry $339.66 Now $335.52 −1.22% settles Nov 19
- Sep 24, 20267w ago 8-K Bullish 6/10 Entry $294.44 to $339.66 Now $335.52 +13.95% ▲ +15.36% +15.78% vs SPY
- Aug 27, 202611w ago Insider Cluster Neutral 3/10 Entry $291.50 to $294.59 Now $335.52 +15.10% ▲ +1.06% +1.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers